Mind Games - Ep 1: Australian swimmer and multiple Olympic medallist, Daniel Kowalski, opens up about his mental struggles during his time as an elite athlete.
Mind Games - Ep 1: Australian swimmer and multiple Olympic medallist, Daniel Kowalski, opens up about his mental struggles during his time as an elite athlete.
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Canaan Inc.
The Law Offices of Frank R. Cruz Announces Investigation of Canaan Inc. (CAN) on Behalf of Investors
The benchmark 10-year Treasury yield was 5.5 basis points higher at 1.5851%. It fell more than 10 basis points on Thursday, the biggest one-day move down since November, amid heavy buying that was attributed to several factors, with traders casting about for a single trigger. Justin Lederer, Treasury analyst at Cantor Fitzgerald in New York, said Japanese buying and "a lot of short covering" were factors in Thursday's rally.
COVINGTON, La., April 16, 2021 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq:POOL) announced today that Melanie Housey Hart, Vice President and Chief Accounting Officer, will be participating in the 24th Annual Burkenroad Reports Investment Conference. Mrs. Hart will be giving a virtual presentation on Friday, April 23, 2021, at 9:00 AM Central Time. Informational materials used during the conference will be posted on POOLCORP’s website on the morning of the conference. Pool Corporation is the world’s largest wholesale distributor of swimming pool and related backyard products. POOLCORP operates approximately 400 sales centers in North America, Europe and Australia through which it distributes more than 200,000 national brand and private label products to roughly 120,000 wholesale customers. For more information about POOLCORP, please visit www.poolcorp.com. This news release may include “forward-looking” statements that involve risk and uncertainties. The forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including impacts on our business from the COVID-19 pandemic, the sensitivity of the swimming pool supply business to weather conditions and other risks detailed in POOLCORP’s 2020 Form 10-K and other reports and filings with the Securities and Exchange Commission (SEC). CONTACT: Curtis J. ScheelDirector of Investor Relations985.firstname.lastname@example.org
In a trading chart that could mirror much of the past year, shares of Chinese electric-vehicle (EV) maker NIO (NYSE: NIO) dropped about 5% early Friday then bounced to a gain of almost 3% before paring that gain as of 3 p.m. EDT.
‘Amazon is going to spend about $650 million in season one alone’
‘This move will empower all the pregnant women in the UK to make the decision that is right for them’
Frontline Ltd. (the “Company”) announces that its 2021 Annual General Meeting will be held on May 26, 2021. A copy of the Notice of Annual General Meeting and associated information including the Company’s Annual Report on Form 20-F for 2020 can be found on our website at www.frontline.bm and attached to this press release. April 16, 2021 The Board of Directors Frontline Ltd. Hamilton, Bermuda This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. Attachments FRO - Notice of Annual General Meeting 2021 FRO - 2020 Annual Report on Form 20-F
Permianville Royalty Trust (NYSE: PVL) (the "Trust") today announced the net profits interest calculation for April 2021. The net profits interest calculation represents reported oil production for the month of January 2021 and reported natural gas production during December 2020. The calculation includes accrued costs incurred in February 2021.
Brigham Minerals, Inc. (NYSE: MNRL) ("Brigham Minerals" or "the Company"), a leading mineral and royalty interest acquisition company, plans to announce first quarter 2021 operating and financial results after market close on Thursday, May 6, 2021. In conjunction with the release, Brigham Minerals will host a conference call to discuss its results on Friday, May 7, 2021, at 11:00 a.m. Eastern Time (10:00 a.m. Central Time).
The Hartford (NYSE: HIG) today announced that it has entered into a Settlement Agreement and Release with the national organization of the Boy Scouts of America (BSA) pursuant to which The Hartford will pay $650 million, before tax, for sexual abuse claims associated with policies mostly issued in the 1970s. The agreement, entered into after extensive negotiations, contemplates that, in exchange for The Hartford’s payment, the BSA and its local councils will fully release The Hartford from any obligation under policies it issued to the BSA and its local councils.
SAN JOSE, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that it experienced strong demand for its paid tests based on the cancer differentiation analysis technology (CDA) technology, or paid CDA-based tests, in the first quarter of 2021, setting a record high Q1 test volume. CDA-based tests, which are multi-cancer tests based on a novel biophysical approach, are the Company’s flagship product line and reached 5,439 paid cancer tests in Q1, an approximately 130% increase over the same period last year. While AnPac Bio offers multiple test products including various cancer screening tests, immunology tests and annual physical checkups, paid CDA-based tests had the highest test volume among all these tests in Q1, 2021. While the first 3 months of the year is traditionally a downtime due to seasonality and the Chinese New Year, the Company still experienced strong demand for its commercial CDA-based tests in Q1 2021. This increase in paid CDA-based test volume was also due to the Company being negatively impacted by COVID-19 in Q1 2020. Dr. Chris Yu commented, “We are very pleased with achieving the increase in Q1 paid CDA-based testing volume, which is a strong indication that AnPac Bio’s technology, services and quality are being recognized by the market. Multi-cancer screening testing is now regarded as an important aspect and breakthrough in the fight again cancer as it offers a more cost effective and efficient way to screen cancer in large populations. With our multi-cancer screening based CDA technology gaining market acceptance, we believe that we are well-positioned to capture the significant growth in the cancer screening market in China. We are also working hard to commercialize our cancer test technology in the US via Laboratory Developed Tests (LDT). We are fully committed to innovating and developing new products and technologies and closely working with customers to achieve continued growth.” About AnPac Bio AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 142 issued patents as of March 31, 2021. With two certified clinical laboratories in China and one CLIA and CAP accredited clinical laboratory and one CLIA registered clinical laboratory in the United States, AnPac Bio performs a suite of cancer screening and detection tests, including CDA (Cancer Differentiation Analysis), bio-chemical, immunological, and genomics tests. According to Frost & Sullivan, AnPac Bio ranked third worldwide among companies offering next-generation early cancer screening and detection technologies in terms of the number of clinical samples for cancer screening and detection, based on approximately 41,700 clinical samples as of December 2019. AnPac Bio’s CDA technology platform has been shown in retrospective validation studies to be able to detect the risk of over 20 different cancer types with high sensitivity and specificity. For more information, please visit: https://www.Anpacbio.com. For investor and media inquiries, please contact: Company:Phil Case, Marketing and Investor RelationsPhone: +1-267-810-6776 (US)Email: phil_case@AnPacbio.com Investor Relations:Ascent Investor Relations LLCTina Xiao, PresidentPhone: +1-917-609-0333 (US)Email: email@example.com Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are made under the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and are relating to the Company's future financial and operating performance. The Company has attempted to identify forward-looking statements by terminologies including "believes," "estimates," "anticipates," "expects," "plans," "projects," "intends," "potential," “target,” “aim,” “predict,” “outlook,” “seek,” “goal” “objective,” “assume,” “contemplate,” “continue,” “positioned,” “forecast,” “likely,” "may," "could," "might," "will," "should," "approximately" or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are based on current expectations, assumptions and uncertainties involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the Company's control. These statements also involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from those expressed or implied by any forward-looking statement. Known and unknown risks, uncertainties and other factors include, but are not limited to, the implementation of our business model and growth strategies; trends and competition in the cancer screening and detection market; our expectations regarding demand for and market acceptance of our cancer screening and detection tests and our ability to expand our customer base; our ability to obtain and maintain intellectual property protections for our CDA technology and our continued research and development to keep pace with technology developments; our ability to obtain and maintain regulatory approvals from the NMPA, the FDA and the relevant U.S. states and have our laboratories certified or accredited by authorities including the CLIA; our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations; general economic and business conditions in China and elsewhere; our ability to hire and maintain key personnel; our relationship with our major business partners and customers; and the duration of the coronavirus outbreaks and their potential adverse impact on the economic conditions and financial markets and our business and financial performance, such as resulting from reduced commercial activities due to quarantines and travel restrictions instituted by China, the U.S. and many other countries around the world to contain the spread of the virus. Additionally, all forward-looking statements are subject to the “Risk Factors” detailed from time to time in the Company's most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission. Because of these and other risks, uncertainties and assumptions, undue reliance should not be placed on these forward-looking statements. In addition, these statements speak only as of the date of this press release and, except as may be required by law, the Company undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
BGI Inc., formerly Bluestem Group Inc. (OTC: BGRP)("BGI" or the "Company"), today announced that, effective as of March 23, 2021, its board of directors (the "Board") has engaged PJ Solomon ("Solomon") to provide financial advisory services in connection with potential strategic alternatives, including a possible merger, joint venture, partnership, business combination, or acquisition of assets or equity interests.
Gores Holdings VIII, Inc. (Nasdaq: GIIXU) (the "Company"), a blank check company sponsored by an affiliate of The Gores Group, LLC, today announced that, commencing April 19, 2021, holders of the units sold in the Company’s initial public offering of 34,500,000 units completed on March 1, 2021 may elect to separately trade the shares of Class A common stock and warrants included in the units. Those units not separated will continue to trade on the Nasdaq Capital Market under the symbol "GIIXU," and the Class A common stock and warrants that are separated will trade on the Nasdaq Capital Market under the symbols "GIIX" and "GIIXW," respectively.
Citigroup Inc. is redeeming, in whole, all the currently outstanding $1.25 billion aggregate liquidation preference of Series Q Depositary Shares representing interests in its 5.950% Fixed Rate / Floating Rate Noncumulative Preferred Stock, Series Q (the "Series Q Preferred Stock").
ANN ARBOR, Mich., April 16, 2021 (GLOBE NEWSWIRE) -- Home Point Capital Inc. (NASDAQ: HMPT) (together with its subsidiaries, “Home Point Capital” or the “Company”), the parent entity of Home Point Financial Corporation (“Homepoint”), announced today that it will release its financial results for the first quarter ended March 31, 2021 before the market opens on May 6, 2021. The Company will host a conference call and live webcast to review the Company’s financial results on the same day at 8:30 a.m. ET. The conference call may be accessed by dialing (800) 768-5901 (toll-free) or (415) 226-5359 (international), using the passcode 21993573. The number should be dialed at least ten minutes prior to the start of the call. A simultaneous webcast will also be available and can be accessed through the Investor Relations section of Home Point Capital’s website at investors.homepoint.com. An investor presentation will be referenced during the call, and it will be available prior to the call through the Investor Relations section of Home Point Capital’s website. A telephonic replay of the call will be available approximately two hours after the live call through Thursday, May 13, 2021 by dialing (844) 512-2921 (toll-free) or (412) 317-6671 (international), passcode 21993573. To access a replay of the webcast, please visit Events in the Investor Relations section of Home Point Capital’s website. About Home Point CapitalHome Point Capital is the parent company of Homepoint, one of the nation’s leading mortgage originators and servicers, as well as wholly owned subsidiaries Home Point Mortgage Acceptance Corporation and Home Point Asset Management. Home Point Capital’s primary business entity, Homepoint, puts people front and center of the homebuying and homeownership experience. The Company supports successful homeownership as a crucial element of broader financial security and well-being through delivering long-term value beyond the loan. Founded in 2015 and headquartered in Ann Arbor, Michigan, Homepoint works with a nationwide network of more than 6,000 mortgage broker and correspondent partners with deep knowledge and expertise about the communities and customers they serve. Today, Homepoint is the nation’s third-largest wholesale mortgage lender and the 7th-largest non-bank mortgage lender. Home Point Financial Corporation d/b/a Homepoint. NMLS No. 7706 (For licensing information, go to: nmlsconsumeraccess.org). Home Point Financial Corporation does not conduct business under the name, "Homepoint" in IL, KY, LA, MD, NY, or WY. In these states, the company conducts business under the full legal name, Home Point Financial Corporation. 2211 Old Earhart Road, Suite 250, Ann Arbor, MI 48105. Toll-Free Tel: 888-616-6866. Investor Relations Contact: Home Point Capital:Gary Steininvestor@hpfc.com(734) 205-9680 Media Contacts: Home Point Capital:Brad Pettifordmedia@hpfc.com Haven Tower for Home Point Capital:firstname.lastname@example.org
Gulf Coast Ultra Deep Royalty Trust (OTC Pink: GULTU) (the Trust) announced today that it will distribute to unitholders a cash distribution totaling $32,589 for the quarter ended March 31, 2021.
The defense team for Huawei's chief financial officer, Meng Wanzhou, will ask a Canadian court to delay upcoming hearings in her U.S. extradition case, the court said on Friday. Meng's U.S. extradition hearings have lasted more than two years and she is scheduled to be back in the British Columbia Supreme Court on April 26. A source familiar with the matter told Reuters the application was a result of an agreement announced last week in a Hong Kong court between Huawei Technologies Co Ltd and HSBC regarding publication of internal documents relating to the fraud allegations against Meng.
Officials hope that missing crew members may have survived in air pockets on overturned ship
Health experts are wary to consider a floor target for COVID-19 cases before recommending the U.S. fully remove restrictions.